Bionoid Pharma, Inc.
BINP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $3 | $2 | $23 |
| Short-Term Investments | – | $0 | $0 | $0 |
| Receivables | – | $0 | $0 | $42 |
| Inventory | – | $0 | $0 | $0 |
| Other Curr. Assets | – | $50 | $59 | -$5 |
| Total Curr. Assets | – | $52 | $62 | $60 |
| Property Plant & Equip (Net) | – | $3 | $3 | $3 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $15 | $18 | $21 |
| Long-Term Investments | – | $40 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | -$40 | $0 | $0 |
| Total NC Assets | – | $19 | $22 | $25 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $71 | $83 | $84 |
| Liabilities | – | – | – | – |
| Payables | – | $0 | $4 | $7 |
| Short-Term Debt | – | $155 | $155 | $155 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $0 | $0 | $0 |
| Other Curr. Liab. | – | -$0 | $0 | $0 |
| Total Curr. Liab. | – | $155 | $159 | $162 |
| LT Debt | – | $4 | $0 | $0 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $0 | $0 | $0 |
| Total NC Liab. | – | $3 | $0 | $0 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $0 | $0 | $0 |
| Total Liabilities | – | $155 | $159 | $162 |
| Equity | – | – | – | – |
| Pref Stock | – | $10 | $0 | $0 |
| Common Stock | – | $5 | $1,458 | $1,458 |
| Retained Earnings | – | -$19,178 | -$20,714 | -$20,715 |
| AOCI | – | $0 | $20,643 | $20,637 |
| Other Equity | – | $19,088 | -$1,464 | -$1,458 |
| Total Equity | – | -$84 | -$76 | -$78 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $71 | $83 | $84 |
| Net Debt | $0 | $156 | $152 | $132 |